Migraine clinical trials in California
18 studies for Migraine are looking for participants at sites in California.
Cities in California
- Concord8 studies
- San Diego6 studies
- Fresno5 studies
- Los Angeles4 studies
- Pomona4 studies
- Anaheim4 studies
- Long Beach4 studies
- Oceanside3 studies
Study of EVO756 in Adults With Migraine
- Buena Park Research Center, Buena Park
- Neuro Pain Research Center, Fresno
- CA Medical Clinic for Headache, Los Angeles
- and 1 more
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Advanced Investigative Medicine, Inc., Hawthorne
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- John Muir Physician Network Clin. Research Center, Walnut Creek
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT06735833Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Advanced Research Center, Inc., Anaheim
- Neuro-Pain Research Center, Fresno
- Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla
- and 4 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Advanced Research Center, Inc., Anaheim
- Adult & Child Neurology Medical Associates, Costa Mesa
- Memorial Health Services, Fountain Valley
- and 9 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Advanced Research Center /ID# 270257, Anaheim
- Neuro Pain Research Center /ID# 271048, Fresno
- Accellacare - Long Beach /ID# 270398, Long Beach
- and 3 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of California San Francisco, San Francisco
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Keck School of Medicine of USC, Los Angeles
- Clinical Research Institute, Los Angeles
- Desert Physicians Medical Group, Palm Springs
- and 1 more
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Advanced Research Center /ID# 227962, Anaheim
- Neuro Pain Research Center /ID# 227966, Fresno
- Imax Clinical Trials /ID# 281436, La Palma
- and 7 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Sunwise Clinical Research, Llc, Walnut Creek
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 2, 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Axiom Research, LLC, Colton
- ProScience Research Group, Culver City
- Leading Edge Research LA, LLC, Encino
- and 15 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924Emgality for Migraine in Breastmilk
- University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 18 to 45 · Women · Updated Aug 11, 2026 · NCT06085144Treatment of Meniere's Disease With Migraine Medications
- University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange
RecruitingPhase 4
Ages 25 to 85 · All sexes · Updated Jun 22, 2026 · NCT05582837A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- The Neurology Center of Southern California - Carlsbad Office, La Jolla
- Clinical Research Institute, LCC, Los Angeles
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated May 19, 2026 · NCT06602479Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
- Peter H Hwang, Stanford
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Apr 27, 2026 · NCT04930887Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Neurology and Pain Specialty Center /ID# 278508, Aliso Viejo
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 10, 2026 · NCT07310290Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
- Stanford University School of Medicine, Stanford
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 23, 2025 · NCT03231241Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #15, La Jolla
RecruitingPhase 4
Ages 6 to 11 · All sexes · Updated Jan 27, 2025 · NCT04748601From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.